Skip to main content

Table 2 Clinical and demographic characteristics for the general control population sample according to genotype.

From: No evidence for an association between the -36A>C phospholamban gene polymorphism and a worse prognosis in heart failure

 

AA

AC + CC

P value

Number

1198

61

-

Age, years

45 ± 11

44 ± 11

-

Gender

   

   Male (%)

45.4

45.9

0.94

Ethnicity (%)

  

0.006

   Blacks

100

0

 

   Mulattos

96.8

3.2

 

   Whites

92.6

7.4

 

   Others

93.8

6.3

 

Biochemical

   

   Total Cholesterol (mg/dL)

205.82 ± 89.68

199.7 ± 63.74

0.47

   Triglycerides (mg/dL)

118.5 ± 96.15

110.62 ± 79.23

0.46

   HDL (mg/dL)

59.84 ± 36.92

60.66 ± 38.68

0.87

   Creatinin (mg/dL)

1.89 ± 2.11

1.93 ± 2,12

0.88

   Glycemia (mg/dL)

93.32 ± 39.12

86.72 ± 30.72

0.11

BMI (kg/m2)

26.37 ± 4.93

27.16 ± 6.38

0.34

Heart Rate (pm)

70.96 ± 11.26

72.59 ± 9

0.48

Diastolic Blood Pressure (mmHg)

83.39 ± 13.43

82.13 ± 12.43

0.44

Systolic Blood Pressure (mmHg)

127.07 ± 21.99

124.05 ± 18.37

0.22